查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596676

脊椎器械和生技藥品市場：按類型、按應用分類 - 2025-2030 年全球預測

Spinal Devices & Biologics Market by Type (Fracture Treatment, Motion Preservation, Non-Fusion Technologies), Application (Ambulatory Surgical Centers, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年脊椎器械和生技藥品市值為97.6億美元，預計2024年將達到113.8億美元，2030年將增加至287.8億美元，預計複合年成長率為16.70%。

脊椎設備和生技藥品市場包括用於治療脊椎疾病的各種醫療保健產品，例如脊椎移植、設備和生物材料。這些產品有助於涉及退化性疾病、創傷和先天畸形的脊椎手術、修復和再生。脊椎疾病盛行率上升、人口老化以及對微創手術的日益偏好推動了對這些產品的需求。適用範圍廣泛，涵蓋退化性疾病、複雜畸形、腫瘤、創傷、慢性脊椎疼痛等病症。典型的最終用戶包括醫院、整形外科診所和門診手術中心，其專家包括從骨科醫生到神經外科醫生等。

主要市場統計
基準年[2023] 97.6億美元
預測年份 [2024] 113.8億美元
預測年份 [2030] 287.8億美元
複合年成長率（%） 16.70%

脊椎器械的技術進步、對改善手術結果的需求增加以及更快的恢復時間推動了成長。然而，該市場也面臨嚴格的監管要求、先進設備的高成本以及可能導致再次手術的術後併發症等挑戰。機會在於下一代微創設備的開發、3D 列印技術在製造中的日益整合，以及幹細胞療法和生長因子等生技藥品增強脊椎融合和再生的潛力。因此，投資於支持加速癒合和融合的生物材料研究是一個成熟的創新領域。

儘管預計將出現顯著成長，但市場受到高研發成本、報銷問題以及產品召回和故障可能性的限制。尋求成長的公司應專注於降低製造成本的創新，確保更安全、更有效的結果，並更有效地通過法律規範。我們專注於個人化脊椎護理解決方案、檢驗新技術的穩健臨床試驗以及技術轉移夥伴關係，有助於降低市場風險並提高競爭力。市場仍然充滿活力並由科學主導，支持持續的研究和開發，以實現永續成長並在脊髓治療的進步中發揮領導作用。

市場動態：揭示快速發展的脊椎器材和生技藥品市場的關鍵市場洞察

供需的動態交互作用正在改變脊椎器械和生技藥品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 退化性脊椎疾病盛行率增加
    • 微創脊椎手術需求激增
    • 脊椎生技藥品技術不斷進步
  • 市場限制因素
    • 產品召回問題
  • 市場機會
    • 脊椎移植和設備的需求不斷成長
    • 擴增實境、內視鏡手術以及改進脊椎手術的 3D 列印植入
  • 市場挑戰
    • 報銷政策的缺點和模糊性

波特的五力：駕馭脊椎器械和生技藥品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解脊椎設備和生技藥品市場的外部影響

外部宏觀環境因素在塑造脊椎器械和生技藥品市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解脊椎器材和生技藥品市場的競爭格局

脊椎設備和生技藥品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣脊椎器械和生技藥品市場供應商的績效評估

FPNV 定位矩陣是評估脊椎設備和生技藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了脊椎器械和生技藥品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對脊椎器械和生技藥品市場進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 退化性脊椎疾病盛行率增加
      • 微創脊椎手術需求快速成長
      • 脊椎生物製藥技術進步
    • 抑制因素
      • 產品召回問題
    • 機會
      • 脊椎移植和設備的需求增加
      • 擴增實境和虛擬實境、內視鏡手術以及改進的用於脊椎手術的 3D 列印植入
    • 任務
      • 退款政策的缺點和模糊性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章脊柱器械和生技藥品市場：按類型

  • 骨折治療
  • 動作儲存
  • 非融合技術
  • 脊椎融合手術

第7章脊椎器械和生技藥品市場：依應用分類

  • 門診手術中心
  • 診所
  • 醫院

第8章美洲脊柱器械和生技藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區脊椎器械和生技藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的脊椎器材和生技藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Acuity Surgical Devices, LLC
  • Aesculap Implant Systems, LLC
  • DJO, LLC
  • Exactech, Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Holdings Corporation
  • Invictus Medical LLC
  • Kohlberg & Company, LLC
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group NV
  • Ossur Group
Product Code: MRR-710B1F0AC641

The Spinal Devices & Biologics Market was valued at USD 9.76 billion in 2023, expected to reach USD 11.38 billion in 2024, and is projected to grow at a CAGR of 16.70%, to USD 28.78 billion by 2030.

The spinal devices and biologics market encompasses a wide range of healthcare products used in the treatment of spinal disorders, including spinal implants, devices, and biologic materials. These products facilitate spinal surgeries, repairs, and regeneration where degenerative conditions, trauma, or congenital deformities are involved. Their necessity stems from the rising prevalence of spinal disorders, an aging population, and an increasing preference for minimally invasive surgical procedures. The application range is vast, covering conditions such as degenerative disc disease, complex deformities, tumors, trauma cases, and chronic spine pain. Primary end-users include hospitals, orthopedic clinics, and ambulatory surgical centers, with specialists ranging from orthopedic surgeons to neurosurgeons.

KEY MARKET STATISTICS
Base Year [2023] USD 9.76 billion
Estimated Year [2024] USD 11.38 billion
Forecast Year [2030] USD 28.78 billion
CAGR (%) 16.70%

Growth is influenced by technological advancements in spinal devices, enhanced surgical outcomes, and a growing demand for reduced recovery times. However, this market also faces challenges such as stringent regulatory requirements, high costs of advanced devices, and potential post-surgical complications leading to revised interventions. Opportunities lie in the development of next-generation minimally invasive devices, increased integration of 3D printing technology in manufacturing, and the potential of biologics, such as stem cell therapies and growth factors, in enhancing spinal fusion and regeneration. Therefore, investing in research on biomaterials that support enhanced healing and fusion processes represents an area ripe for innovation.

Despite strong growth prospects, the market is limited by high research and development costs, reimbursement issues, and potential product recalls or malfunctions. Companies aiming for growth should focus on innovations that lower production costs, ensure safer and more effective outcomes, and navigate regulatory frameworks efficiently. Emphasis on personalized spinal care solutions, robust clinical trials validating new technologies, and partnerships for technology transfers can mitigate market risks and enhance competitiveness. The market remains dynamic and science-driven, favoring continual research and development for sustainable growth and leadership in spinal care advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spinal Devices & Biologics Market

The Spinal Devices & Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of degenerative spine disorders
    • Surging demand for minimally invasive spine surgery
    • Growing technological advancements in spine biologics
  • Market Restraints
    • Issues related to product recalls
  • Market Opportunities
    • Rising demand for spinal implants and devices
    • Improvement in augmented & virtual reality, endoscopic surgery, and 3D printed implants for spine surgery
  • Market Challenges
    • Unfavorable and ambiguity in reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Spinal Devices & Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spinal Devices & Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spinal Devices & Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spinal Devices & Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spinal Devices & Biologics Market

A detailed market share analysis in the Spinal Devices & Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spinal Devices & Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spinal Devices & Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spinal Devices & Biologics Market

A strategic analysis of the Spinal Devices & Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spinal Devices & Biologics Market, highlighting leading vendors and their innovative profiles. These include Acuity Surgical Devices, LLC, Aesculap Implant Systems, LLC, DJO, LLC, Exactech, Inc., Innovasis, Inc., Integra LifeSciences Holdings Corporation, Invictus Medical LLC, Kohlberg & Company, LLC, Medtronic PLC, NuVasive, Inc., Orthofix Medical Inc., Smith & Nephew PLC, Stryker Corporation, Wright Medical Group N.V., and Ossur Group.

Market Segmentation & Coverage

This research report categorizes the Spinal Devices & Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Fracture Treatment, Motion Preservation, Non-Fusion Technologies, and Spinal Fusion & Fixation.
  • Based on Application, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of degenerative spine disorders
      • 5.1.1.2. Surging demand for minimally invasive spine surgery
      • 5.1.1.3. Growing technological advancements in spine biologics
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for spinal implants and devices
      • 5.1.3.2. Improvement in augmented & virtual reality, endoscopic surgery, and 3D printed implants for spine surgery
    • 5.1.4. Challenges
      • 5.1.4.1. Unfavorable and ambiguity in reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spinal Devices & Biologics Market, by Type

  • 6.1. Introduction
  • 6.2. Fracture Treatment
  • 6.3. Motion Preservation
  • 6.4. Non-Fusion Technologies
  • 6.5. Spinal Fusion & Fixation

7. Spinal Devices & Biologics Market, by Application

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Spinal Devices & Biologics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Spinal Devices & Biologics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Spinal Devices & Biologics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acuity Surgical Devices, LLC
  • 2. Aesculap Implant Systems, LLC
  • 3. DJO, LLC
  • 4. Exactech, Inc.
  • 5. Innovasis, Inc.
  • 6. Integra LifeSciences Holdings Corporation
  • 7. Invictus Medical LLC
  • 8. Kohlberg & Company, LLC
  • 9. Medtronic PLC
  • 10. NuVasive, Inc.
  • 11. Orthofix Medical Inc.
  • 12. Smith & Nephew PLC
  • 13. Stryker Corporation
  • 14. Wright Medical Group N.V.
  • 15. Ossur Group

LIST OF FIGURES

  • FIGURE 1. SPINAL DEVICES & BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPINAL DEVICES & BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPINAL DEVICES & BIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY FRACTURE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MOTION PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY NON-FUSION TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL FUSION & FIXATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023